The Pharma Letter21h
New ADC focus as Sutro slashes workforce, drops lead drug
Sutro Biopharma (Nasdaq: STRO), a US biotechnology company, has announced significant organizational changes, including a ...
OBI Pharma Receives ‘Most Promising ADC Clinical Candidate in Taiwan’ Award
Dr. Heidi Wang Accepts Award on Behalf of OBI Pharma at ADC Asia Congress 2025 and Gives a PresentationTAIPEI, Taiwan, March ...
EQS-News: Heidelberg Pharma Amends Royalty Financing with HealthCare Royalty
Ladenburg, Germany, 13 March 2025 – Heidelberg Pharma AG (FSE: HPHA), a clinical stage biotech Company developing innovative Antibody Drug Conjugates (ADCs), and HealthCare Royalty (HCRx) today ...
EQS-Adhoc: Heidelberg Pharma Amends Royalty Financing with HealthCare Royalty
Ladenburg, Germany, 12 March 2025 – Heidelberg Pharma AG (FSE: HPHA), a clinical stage biotech Company developing innovative Antibody Drug Conjugates (ADCs), and HealthCare Royalty (HCRx) today ...
Morningstar3d
OBI Pharma Receives ‘Most Promising ADC Clinical Candidate in Taiwan’ Award
TAIPEI, Taiwan, March 12, 2025 (GLOBE NEWSWIRE) -- At the ADC Asia Congress 2025 held today (3/12) in Singapore, OBI Pharma (4174.TWO) was honored with the "Most Promising ADC Clinical Candidate ...
Financial Post3d
OBI Pharma Receives 'Most Promising ADC Clinical Candidate in Taiwan' Award
TAIPEI, Taiwan, March 12, 2025 (GLOBE NEWSWIRE) — At the ADC Asia Congress 2025 held today (3/12) in Singapore, OBI Pharma (4174.TWO) was honored with the “Most Promising ADC Clinical Candidate in ...